TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Chinese vaccine could be ready by year-end, government body says
Change text size
Gift Premium Articles
to Anyone
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
A worker is seen inside the Beijing Applied Biological Technologies (XABT) research and development laboratory in Beijing on May 14, 2020. (AFP/Nicolas Asfouri)
A
Chinese-made coronavirus vaccine could be ready for market as early as the end of this year, China's State-owned Assets Supervision and Administration Commission (SASAC) said in a social media post.
In trials, more than 2,000 people have received vaccines developed by the Wuhan Institute of Biological Products and the Beijing Institute of Biological Products. A vaccine could be ready for the market as early as the end of this year or early 2021, according to the May 29 post on Chinese social media platform WeChat.
Read also: Kalbe to start COVID-19 vaccine trial with S. Korean pharma firm
Vaccines from the Wuhan Institute of Biological Products and the Beijing Institute of Biological Products had entered Phase II clinical trials. Both groups are affiliated with state-owned pharmaceutical group Sinopharm, whose management is overseen by SASAC.
The Beijing Institute of Biological Products' production line will have an annual manufacturing capacity of 100 million to 120 million doses, according to the article.
China has five coronavirus vaccines in human trials. Neither company could be reached for comment on Saturday evening.
